CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
4.120
-0.170 (-3.96%)
At close: Apr 28, 2026, 4:00 PM EDT
4.130
+0.010 (0.24%)
Pre-market: Apr 29, 2026, 7:09 AM EDT
CytomX Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 12.67 | 38.05 | 17.17 | 193.65 | 205.53 | Upgrade
|
| Short-Term Investments | 124.39 | 62.57 | 157.34 | - | 99.7 | Upgrade
|
| Cash & Short-Term Investments | 137.05 | 100.62 | 174.51 | 193.65 | 305.23 | Upgrade
|
| Cash Growth | 36.20% | -42.34% | -9.88% | -36.55% | -3.45% | Upgrade
|
| Receivables | 2.01 | 3.1 | 3.43 | 35.99 | 0.79 | Upgrade
|
| Prepaid Expenses | 4.86 | 3.58 | 5 | 7.47 | 4.29 | Upgrade
|
| Total Current Assets | 143.92 | 107.31 | 182.94 | 237.1 | 310.3 | Upgrade
|
| Property, Plant & Equipment | 4.7 | 10.6 | 16.18 | 21.02 | 25.32 | Upgrade
|
| Goodwill | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | Upgrade
|
| Other Intangible Assets | 0.44 | 0.58 | 0.73 | 0.88 | 1.02 | Upgrade
|
| Other Long-Term Assets | 1.56 | 1.09 | 1 | 0.94 | 1.82 | Upgrade
|
| Total Assets | 151.57 | 120.53 | 201.79 | 260.89 | 339.41 | Upgrade
|
| Accounts Payable | 1.3 | 1.09 | 1.46 | 2.81 | 2.82 | Upgrade
|
| Accrued Expenses | 14.17 | 12.34 | 17.6 | 22.82 | 30.62 | Upgrade
|
| Current Portion of Leases | 4.24 | 5.15 | 4.59 | 4.08 | 3.62 | Upgrade
|
| Current Unearned Revenue | 26.88 | 67.2 | 132.27 | 121.27 | 40.82 | Upgrade
|
| Other Current Liabilities | 0.02 | - | - | 1.63 | - | Upgrade
|
| Total Current Liabilities | 46.62 | 85.77 | 155.91 | 152.61 | 77.87 | Upgrade
|
| Long-Term Leases | - | 4.24 | 9.39 | 13.98 | 18.06 | Upgrade
|
| Long-Term Unearned Revenue | 1.59 | 26.86 | 80.05 | 180.06 | 243.94 | Upgrade
|
| Other Long-Term Liabilities | 4.35 | 4.12 | 3.89 | - | - | Upgrade
|
| Total Liabilities | 52.56 | 120.99 | 249.24 | 346.64 | 339.87 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 810.84 | 691.1 | 675.91 | 637.12 | 623.34 | Upgrade
|
| Retained Earnings | -711.95 | -691.58 | -723.45 | -722.88 | -623.56 | Upgrade
|
| Comprehensive Income & Other | 0.11 | 0.03 | 0.1 | 0.01 | -0.24 | Upgrade
|
| Shareholders' Equity | 99.01 | -0.46 | -47.45 | -85.75 | -0.46 | Upgrade
|
| Total Liabilities & Equity | 151.57 | 120.53 | 201.79 | 260.89 | 339.41 | Upgrade
|
| Total Debt | 4.24 | 9.39 | 13.97 | 18.06 | 21.67 | Upgrade
|
| Net Cash (Debt) | 132.81 | 91.24 | 160.54 | 175.59 | 283.55 | Upgrade
|
| Net Cash Growth | 45.57% | -43.17% | -8.58% | -38.07% | -2.64% | Upgrade
|
| Net Cash Per Share | 0.96 | 1.08 | 2.18 | 2.67 | 4.42 | Upgrade
|
| Filing Date Shares Outstanding | 170.19 | 80.1 | 67.72 | 66.23 | 65.39 | Upgrade
|
| Total Common Shares Outstanding | 170.19 | 80.1 | 67.31 | 66.23 | 65.39 | Upgrade
|
| Working Capital | 97.31 | 21.53 | 27.02 | 84.49 | 232.43 | Upgrade
|
| Book Value Per Share | 0.58 | -0.01 | -0.70 | -1.29 | -0.01 | Upgrade
|
| Tangible Book Value | 97.62 | -1.99 | -49.13 | -87.58 | -2.43 | Upgrade
|
| Tangible Book Value Per Share | 0.57 | -0.02 | -0.73 | -1.32 | -0.04 | Upgrade
|
| Machinery | 16.62 | 16.69 | 16.3 | 17 | 17.75 | Upgrade
|
| Construction In Progress | - | - | 0.37 | 0.71 | 0.31 | Upgrade
|
| Leasehold Improvements | 1.6 | 2.01 | 1.98 | 1.74 | 1.74 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.